CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 85 filers reported holding CHEMOCENTRYX INC in Q3 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $262,000 | +274.3% | 5,074 | +78.8% | 0.00% | – |
| Q2 2022 | $70,000 | -48.5% | 2,838 | -47.6% | 0.00% | – |
| Q1 2022 | $136,000 | -67.1% | 5,415 | -52.4% | 0.00% | – |
| Q4 2021 | $414,000 | +157.1% | 11,382 | +20.8% | 0.00% | – |
| Q3 2021 | $161,000 | +36.4% | 9,421 | +7.1% | 0.00% | – |
| Q2 2021 | $118,000 | +1.7% | 8,794 | +288.1% | 0.00% | – |
| Q1 2021 | $116,000 | +625.0% | 2,266 | +781.7% | 0.00% | – |
| Q4 2020 | $16,000 | +14.3% | 257 | 0.0% | 0.00% | – |
| Q3 2020 | $14,000 | -89.6% | 257 | -88.9% | 0.00% | – |
| Q2 2020 | $134,000 | +737.5% | 2,318 | +495.9% | 0.00% | – |
| Q1 2020 | $16,000 | +1500.0% | 389 | +980.6% | 0.00% | – |
| Q4 2019 | $1,000 | -75.0% | 36 | -87.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 277 | +2208.3% | 0.00% | – |
| Q2 2018 | $0 | – | 12 | +300.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 3 | -98.1% | 0.00% | – |
| Q4 2017 | $1,000 | -93.8% | 157 | -92.6% | 0.00% | – |
| Q3 2017 | $16,000 | +300.0% | 2,132 | +252.4% | 0.00% | – |
| Q1 2017 | $4,000 | +100.0% | 605 | +142.0% | 0.00% | – |
| Q4 2016 | $2,000 | – | 250 | +614.3% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 35 | -97.4% | 0.00% | – |
| Q3 2015 | $8,000 | -42.9% | 1,348 | -18.7% | 0.00% | – |
| Q2 2015 | $14,000 | – | 1,658 | +33060.0% | 0.00% | – |
| Q1 2015 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |